Trials / Recruiting
RecruitingNCT05629611
Efficacy and Safety Evaluation of Vi-sealer
Efficacy and Safety Evaluation of Advanced Vessel Sealing Device (Vi-sealer)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 280 (estimated)
- Sponsor
- Hyun Park · Academic / Other
- Sex
- Female
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study's primary goal is to compare the efficacy and safety of the novel advanced hemostatic device(AHD), Vi-Sealer, with conventional AHDs in laparoscopic total hysterectomy for patients with benign gynecologic neoplasm.
Detailed description
Vi-Sealer is a reusable advanced bipolar electrode with an interchangeable blade. This study evaluates the efficacy and safety of the Vi-Sealer by comparing it with other advanced hemostatic devices, such as Ligasure, Enseal, Thunderbeat, Harmonic scalpel, etc. The economic evaluation of the device compared with other disposable devices would also be conducted.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vi-Sealer | using Reusable device, Vi-Sealer |
| DEVICE | Ligasure | using Ligasure |
| DEVICE | Other AHD | Using other AHDs such as Thunderbeat, Harmonic scalpel, Caiman®, Enseal, etc. except Ligasure |
Timeline
- Start date
- 2023-01-20
- Primary completion
- 2024-12-01
- Completion
- 2025-10-31
- First posted
- 2022-11-29
- Last updated
- 2024-10-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05629611. Inclusion in this directory is not an endorsement.